Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 441 word(s) 441 2020-12-15 08:04:20

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Guo, L. PFKM Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5745 (accessed on 29 March 2024).
Guo L. PFKM Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5745. Accessed March 29, 2024.
Guo, Lily. "PFKM Gene" Encyclopedia, https://encyclopedia.pub/entry/5745 (accessed March 29, 2024).
Guo, L. (2020, December 25). PFKM Gene. In Encyclopedia. https://encyclopedia.pub/entry/5745
Guo, Lily. "PFKM Gene." Encyclopedia. Web. 25 December, 2020.
PFKM Gene
Edit

phosphofructokinase, muscle

genes

1. Introduction

The PFKM gene provides instructions for making one piece (the PFKM subunit) of an enzyme called phosphofructokinase. This enzyme plays a role in the breakdown of a complex sugar called glycogen, which is a major source of stored energy in the body. The phosphofructokinase enzyme is made up of four subunits and is found in a variety of tissues. Different combinations of subunits are found in different tissues. In muscles used for movement (skeletal muscles), the phosphofructokinase enzyme is composed solely of subunits produced from the PFKM gene.

The cells' main source of energy is stored as glycogen. Glycogen can be broken down rapidly into the simple sugar glucose when energy is needed, for instance to maintain normal blood sugar levels between meals or for energy during exercise. Phosphofructokinase composed of PFKM subunits is involved in the sequence of events that breaks down glycogen to provide energy to muscle cells. Specifically, the enzyme converts a molecule called fructose-6-phosphate to a molecule called fructose 1,6-bisphosphate.

2. Health Conditions Related to Genetic Changes

2.1. Glycogen storage disease type VII

At least 20 mutations in the PFKM gene have been found to cause glycogen storage disease type VII (GSDVII). This condition is characterized by an inability to break down glycogen in muscle cells, resulting in muscle cramps and weakness that can vary in severity among affected individuals. PFKM gene mutations that cause GSDVII result in the production of PFKM subunits that have little or no function. One PFKM gene mutation accounts for most cases of GSDVII in people with Ashkenazi Jewish ancestry. This mutation (written as IVS5+1G>A) results in a small deletion of genetic material within the gene, which alters the way the gene's instructions are pieced together and causes a nonfunctional subunit to be produced.

Without functional PFKM subunits, no functional phosphofructokinase is formed in skeletal muscles and glycogen cannot be completely broken down. Partially broken down glycogen builds up in muscle cells. Muscles that do not have access to glycogen as an energy source become weakened and cramped following moderate strain, such as exercise, and in some cases, begin to break down. In other tissues, other subunits that make up the phosphofructokinase enzyme likely compensate for the lack of PFKM subunits, and the enzyme is able to retain some function. This compensation may help explain why other tissues are not affected by PFKM gene mutations. It is unclear why some individuals with GSDVII are more severely affected than others.

3. Other Names for This Gene

  • 6-phosphofructo-1-kinase
  • 6-phosphofructokinase, muscle type
  • K6PF_HUMAN
  • PFK-1
  • PFK-A
  • PFK1
  • PFKA
  • PFKX
  • phosphofructo-1-kinase isozyme A
  • phosphofructokinase 1
  • phosphofructokinase, polypeptide X
  • phosphofructokinase-M
  • phosphohexokinase

References

  1. Brüser A, Kirchberger J, Kloos M, Sträter N, Schöneberg T. Functional linkage of adenine nucleotide binding sites in mammalian muscle 6-phosphofructokinase. J Biol Chem. 2012 May 18;287(21):17546-53. doi: 10.1074/jbc.M112.347153.
  2. Schöneberg T, Kloos M, Brüser A, Kirchberger J, Sträter N. Structure andallosteric regulation of eukaryotic 6-phosphofructokinases. Biol Chem. 2013Aug;394(8):977-93. doi: 10.1515/hsz-2013-0130. Review.
  3. Vives-Corrons JL, Koralkova P, Grau JM, Mañú Pereira Mdel M, Van Wijk R. Firstdescription of phosphofructokinase deficiency in spain: identification of a novelhomozygous missense mutation in the PFKM gene. Front Physiol. 2013 Dec 30;4:393. doi: 10.3389/fphys.2013.00393.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 318
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020
1000/1000